Live Breaking News & Updates on Marrow transplant research

Stay updated with breaking news from Marrow transplant research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ISCT Leads Global Scientific Consortia to Respond to Recent FDA Report on Risk of T-Cell Malignancy in Patients Following CAR T-Cell Immunotherapies

/PRNewswire/ - The International Society for Cell & Gene Therapy (ISCT), the global society of clinicians, researchers, regulators, technologists, and industry...

United-states , Vancouver , British-columbia , Canada , American , Bruce-levine , International-society-for-cell-gene-therapy , Parker-institute-for-cancer-immunotherapy , International-blood , European-society-for-blood , American-society-for-transplantation , Us-food-drug-administration

Cell therapy bigwigs endorse CAR-T in Nature Medicine article amid FDA safety probe

Cell therapy bigwigs endorse CAR-T in Nature Medicine article amid FDA safety probe
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

United-states , American , Miguel-angel-perales , Anna-sureda , Novarti-kymriah , Bristol-myers-squibb-breyanzi , Bruce-levine , International-blood , European-society-for-bone-marrow-transplantation , American-society-for-transplantation , Marrow-transplant-research , Johnson

Developing point-of-care CAR T manufacturing

Developing point-of-care CAR T manufacturing
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

Jerusalem , Israel-general- , Israel , Hebrew-university , Yerushalayim , Arnon-nagler , Drug-administration , Accreditation-committee , Oncology-center , European-haematology-association , Sheba-medical-center , Hadassah-medical-school

New Analyses Presented at ASH 2023 Support the Potential Long-Term Response and Safety of Kite's Tecartus® in Patients With Aggressive Blood Cancers

New Analyses Presented at ASH 2023 Support the Potential Long-Term Response and Safety of Kite's Tecartus® in Patients With Aggressive Blood Cancers
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United-states , Foster-city , California , American , Andre-goy , Swetha-kambhampati , Frank-neumann , Santa-monica , Evandro-bezerra , Gilead-sciences-inc , Hackensack-university-medical-center , Ohio-state-university-comprehensive-cancer-center

Relapsed DLBCL: Complete Interim Response, SCT Beats CAR T

'In patients with relapsed DLBCL in a complete remission, treatment with auto-HCT is associated with a lower rate of relapse/progression, and a longer progression-free survival [versus CAR T therapy].'

San-diego , California , United-states , New-york , University-of-rochester , American , Morphosys-incyte , Mazyar-shadman , Jonathanw-friedberg , Bristol-myers-squibb , American-society-of-hematology , International-blood-marrow-transplant-research

Cell therapy appears safe and effective for l

<p>A study led by researchers at <a href="https://umiamihealth.org/en/sylvester-comprehensive-cancer-center"><strong>Sylvester Comprehensive Cancer Center</strong></a> suggests that CAR-T immunotherapy remains a viable option for patients who have lymphoma that goes into remission before the cell therapy begins. Video available.</p>

Miami , Florida , United-states , San-diego , California , American , Mazyar-shadman , Antoniom-jimenez , Mehdi-hamadani , Alexf-herrera , Kwang-wooahn , Manmeet-kaur

Stem Cell Transplants Improves Survival Without Progression in Relapsed LBCL Subset

Autologous hematopoietic cell transplantation, compared with CAR-T cell therapy, resulted in lower rates of relapse and improved progression-free survival in patients with relapsed large B-cell lymphoma while they were in complete response.

Mazyar-shadman , International-blood , National-cancer-institute , Clinical-research-division , Fred-hutch-cancer-center , Marrow-transplant-research , Innovators-network , Innovators-network-endowed-chair , News , Conference , Lymphoma

ASCT Tops CAR T-Cell Therapy for Relapsed LBCL in Complete Remission

Better 2-year PFS, OS, but not applicable to primary refractory disease

United-states , American , Mazyar-shadman , Mikkael-sekeres , Charles-bankhead , University-of-miami-sylvester-comprehensive-cancer-center , International-blood-marrow-transplant-research , Fred-hutchinson-cancer-center , University-of-washington , American-society-of-hematology , American-society , Miami-sylvester-comprehensive-cancer

Cell therapy appears safe and effective for lymphoma in remission

Cell therapy appears safe and effective for lymphoma in remission
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

San-diego , California , United-states , Miami , Florida , American , Trent-wang , A-center , University-of-miami-miller-school-medicine , Sylvester-comprehensive-cancer-center , American-society-of-hematology , International-blood-marrow-transplant-research

As FDA puts CAR-T safety under microscope, researchers dig into adverse events record of BCMA therapies

As FDA puts CAR-T safety under microscope, researchers dig into adverse events record of BCMA therapies
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

United-states , American , Bristol-myers-squibb , Rahul-banerjee , Ying-huang , David-miklos , Abecma-karmma , Johnson , Stanford-university , American-society-of-hematology , Fred-hutch-cancer-center , International-blood-marrow-transplant-research